IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation

Journal of the American Society of Nephrology

Volumn 17, Issue 8, 2006, Pages 2333-2340

  Bamoulid, Jamal ^a,b   Courivaud, Cécile ^a,b   Deschamps, Marina ^a,c   Mercier, Patricia ^a,c   Ferrand, Christophe ^a,c   Penfornis, Alfred ^d   Tiberghien, Pierre ^a,b,c   Chalopin, Jean Marc ^a,b   Saas, Philippe ^a,c   Ducloux, Didier ^a,b  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b HÔPITAL SAINT JACQUES   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTICLE; COHORT ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEW ONSET DIABETES AFTER TRANSPLANTATION; OBESITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RECIPIENT; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 33746581258     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006010066     Document Type: Article

References (33)

1. Davidson J, Wilknson A, Dantal J, Dotta F, Haller H, Hernandez D, Kasiske BL, Kiberd B, Krentz A, Legendre C, Marchetti P, Markell M, van der Woude FJ, Wheeler DC; International Expert Panel: New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceeding of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75[Suppl]: SS3-SS24, 2003
2. Pickup JC, Crook MA: Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-1248, 1998
3. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF: Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817, 2003
4. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE: Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53: 693-700, 2004
5. Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N: Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 26: 2754-2757, 2003
6. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334, 2001
7. Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Hanne-Parikka P, Keinanen-Kinkaanniemi S, Tuomilehto J, Uusitupa M, Laakso M: Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: The Finnish Diabetes Prevention Study. Diabetes 52: 1872-1876, 2003
8. Herbert A, Lin C, Karamohamed S, Schiller J, Lin J, Yang Q, Wilson PW, Cupples LA, Meigs JB: The -174 IL-6 GG genotype is associated with a reduced risk of type 2 diabetes mellitus in a family sample from the National Heart, Lung and Blood Institute's Framingham Heart Study. Diabetologia 48: 1492-1495, 2005
9. Vozarova B, Fernandez-Real J-M, Knowler WC, Gallart L, Hanson RL, Gruber JD, Ricart W, Vendreli J, Richart C, Tataranni PA, Wolford JK: The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in native Americans and Caucasians. Hum Genet 112: 409-413, 2003
10. Babel N, Cherepnev G, Kowalenko A, Horstrup J, Volk H-D, Reinke P: Nonimmunologic complications and gene polymorphisms of immunoregulatory cytokines in long-term renal transplants. Kidney Int 66: 428-432, 2004
11. Ducloux D, Challier B, Saas P, Tiberghien P, Chalopin JM: CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. J Am Soc Nephrol 14: 767-772, 2003
12. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988
13. Depboylu C, Lohmuller F, Gocke P, Du Y, Zimmer R, Gasser T, Klockgether T, Dodel RC: An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease. Dement Geriatr Cogn Disord 17: 170-173, 2004
14. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376, 1998
15. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 265: 621-636, 1990
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28: 412-419, 1985
17. Hamid YH, Rose CS, Urhammer SA, Glumer C, Nolsoe R, Kristiansen OP, Mandrup-Poulsen T, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O: Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 48: 251-260, 2005
18. Fernandez-Real J-M, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M, Richart C, Ricart W: Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49: 517-520, 2000
19. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE: Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arteriosder Thromb Vasc Biol 21: 1458-1463, 2001
20. Pawlik A, Domanski L, Rozanski J, Florczak M, Wrzesniewska J, Dutkiewicz G, Dabrowska-Zamojcin E, Gawronska-Szklarz B: The cytokine gene polymorphisms in patients with chronic kidney graft rejection. Transpl Immunol 14: 49-52, 2005
21. Muller-Steinhardt M, Fricke L, Muller B, Ebel B, Kirchner H, Hartel C: Cooperative influence of the interleukin-6 promoter polymorphisms -597, -572 and -174 on long-term kidney allograft survival. Am J Transplant 4: 402-406, 2004
22. Weimer R, Mytilineos J, Feustel A, Preiss A, Daniel V, Grimm H, Wiesel M, Opelz G: Mycophenolate mofetil-based immunosuppression and cytokine genotypes: Effects on monokines secretion and antigen presentation in long-term renal transplant recipients. Transplantation 75: 2090-2099, 2005
23. Fantuzzi G: Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911-919, 2005
24. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC: Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 25: 583-592, 2002
25. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3: 178-185, 2003
26. Ducloux D, Kazorv A, Chalopin JM: Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 79: 438-443, 2005
27. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75-79, 2002
28. Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA: Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: Absence of development of age-related obesity. Am J Physiol Endocrinol Metab 287: E182-E187, 2004
29. Stith RD, Luo J: Endocrine and carbohydrate responses to interleukin-6 in vivo. Circ Shock 44: 210-215, 1994
30. Ritchie DG: Interleukin-6 stimulates hepatic glucose release from prelabeled glycogen pools. Am J Physiol 258: E57-E64, 1990
31. Senn JJ, Klover PJ, Nowak IA, Mooney RA: Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51: 3391-3399, 2002
32. Kim H-J, Higashimori T, Park SY, Choi H, Dong J, Kim Y-J, Noh H-L, Cho Y-R, Cline G, Kim Y-B, Kim JK: Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53: 1060-1067, 2004
33. Muller-Steinhardt M, Hartel C, Muller B, Kirchner H, Fricke L: The interleukin-6 -174 promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int 62: 1824-1827, 2002